Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target...
cancer
MSD is continuing with its clinical development programme in lung cancer. Credit: Soloviova Liudmyla / Shutterstock. MSD (Merck & Co)...
Medical physicists apply their knowledge of physics to a variety of treatments, devices and technologies to provide the best care...
In this Proposed Intelligent System for Multidisciplinary Cancer Disease Prediction, It presents how adaptive federated learning is used in the...
In an interview with Harold "Hal" J Burstein, MD, PhD, clinician and clinical investigator at Dana-Farber Cancer Institute and Brigham...
Jennifer Keys, 40, was diagnosed with an aggressive form of non-Hodgkin lymphoma last June.Living in Terrace, B.C., with her husband...
